INVESTINGADP Is a Dividend Aristocrat That Outperforms in Both Good and Bad TimesBy Jason OrestesOct 17, 2019 1:38 PM EDT
JIM CRAMERLockheed Martin, Nucor, Alibaba: 'Mad Money' Lightning RoundBy Scott RuttAug 13, 2019 8:52 PM EDT
MARKETSU.S. Jobs Grew in March at Slowest Pace in 18 Months, ADP SaysBy Bradley KeounApr 3, 2019 9:27 AM EDT
JIM CRAMERAutomatic Data Processing, ADT, Abiomed: 'Mad Money' Lightning RoundBy Scott RuttJun 12, 2018 6:36 AM EDT
JIM CRAMEREmotions Are Running This Market: Cramer's 'Mad Money' RecapBy Scott RuttMay 9, 2018 6:27 AM EDT
MERGERS AND ACQUISITIONSAckman Needs A Big Win At ADP or Another Target To Stop the BleedingBy Ronald OrolApr 5, 2018 2:28 PM EDT
MERGERS AND ACQUISITIONSBill Ackman's Message to Nike Is - Just Do ItBy Ronald OrolJan 31, 2018 12:16 PM EST
OPINIONThe S&P 500 Has Gone Parabolic, So Hurry Up and Buy These 22 StocksBy Brian SozziJan 29, 2018 6:06 AM EST
JIM CRAMERDon't Miss This Chance to Buy: Cramer's 'Mad Money' RecapBy Scott RuttJan 22, 2018 8:59 PM EST
VIDEOClosing Bell: Stocks Push Higher on Dow 25,000 and Upbeat Jobs ReportBy Kinsey GrantJan 4, 2018 4:17 PM EST
MERGERS AND ACQUISITIONS5 Things We Learned About Activist Investing in 2017By Ronald OrolDec 30, 2017 10:12 AM EST
STOCKSU.S. Companies Can't Find Good Human Workers so Own These 14 Tech StocksBy Brian SozziDec 16, 2017 7:56 AM EST
MERGERS AND ACQUISITIONSThese Are the Biggest Winners and Losers in Activist Investing This YearBy Ronald OrolDec 11, 2017 7:04 AM EST
JIM CRAMERMasco, Diplomat Pharmacy, Vail Resorts: 'Mad Money' Lightning RoundBy Scott RuttDec 1, 2017 6:51 AM EST
